Check-Cap EBIT

As of the most recent data (December 2024), CHEK shows a EBIT of $-9.5M. That compares with $-17M in the prior-year period — up 42.9% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CHEK's EBIT is now $-9.5M (was $-17M) — a 42.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Check-Cap is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. Check-Cap is at $-9.5M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how CHEK stacks up against individual peers as well.

Tracking CHEK's ebit over time shows whether Check-Cap is scaling, shrinking, or reshaping that part of the business. The current reading is $-9.5M That compares with $-17M in the prior-year period — up 42.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Check-Cap's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-9.5M) with ownership activity and broader fundamentals.